.loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people. . is putting his shoulder into legislation that would help others access the same sort of care he received when he suffered a stroke midway through his playing career. .
staff blog: medicine matters
.
.
.